Health Services Utilization During the COVID-19 Pandemic
COVID-19 大流行期间卫生服务的利用
基本信息
- 批准号:10446307
- 负责人:
- 金额:$ 48.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAdoptionAffectBusinessesCOVID-19COVID-19 disparityCOVID-19 pandemicCOVID-19 pandemic effectsCOVID-19 patientCOVID-19 vaccinationCantorCaringCenters of Research ExcellenceCharacteristicsClinicalContinuity of Patient CareCountyDataData SetElderlyEnsureFaceFee-for-Service PlansFinancial HardshipFinancial SupportFundingHealthHealth ServicesHealth Services AccessibilityHealth systemHealthcare SystemsHomeLeadLow incomeMeasuresMedicareModalityNatural experimentOperative Surgical ProceduresOrganizational ChangeOutcomePatient CarePatient-Focused OutcomesPatientsPatternPatterns of CarePerformancePersonsPhysiciansPoliciesPopulationPositioning AttributePrivatizationProceduresProviderPublishingQuality of CareResearch PersonnelResourcesRisk FactorsRunningRuralServicesShockSocial DistanceSystemTechnologyTelemedicineTravelUnited StatesUnited States Agency for Healthcare Research and QualityUnited States Centers for Medicare and Medicaid ServicesVariantVisitWorkcare deliverycare outcomescoronavirus diseasedesignethnic minority populationexperiencehealth care deliveryhealth care disparityhealth care service utilizationhealth service useimprovedmedical vulnerabilitymultiple chronic conditionsorganizational structurepandemic diseasepatient populationpatient subsetspaymentprovider adoptionpublic health emergencyracial and ethnicracial minorityresilienceresponsesocialsocial vulnerabilitytelehealth
项目摘要
PROJECT SUMMARY/ABSTRACT
The COVID-19 pandemic has created an unprecedented shock to the U.S. health care system and to care
delivery for patients. As documented by the study team, the COVID-19 pandemic suddenly and dramatically
changed health care utilization patterns, including a rapid escalation in use of telehealth services, an abrupt
decline in in-person services, and a large volume of deferred services. It is unclear how these care patterns will
evolve over the course of the pandemic (e.g., the degree to which deferred services will occur later, telehealth
will substitute for in-person services, and new levels of telehealth services will be sustained), much less in the
years following the COVID-19 pandemic, and how continuing care patterns will differ for socially and clinically
vulnerable patient populations. Physician organizations (POs) face differing burdens in rapidly adopting
telemedicine, and PO barriers to telemedicine adoption may be reflected in the outcomes of patients treated by
these POs. The reduction in in-person care has placed financial stress on many POs, leading to concerns that
many POs may go out of business or consolidate. The impacts of care reductions, the adoption of telemedicine
as a new care delivery modality, and access to POs are likely to have larger effects among vulnerable patient
populations, including lower-income, rural, and racial/ethnic minority populations, and patients with multiple
chronic conditions. Understanding patient and provider responses to the COVID-19 public health crisis and the
care patients receive, particularly those who are medically and socially vulnerable, is essential to inform
immediate-term and longer-term policymaking intended to help the health delivery system respond to COVID-
19. We propose to conduct a set of analyses to 1) Estimate how health services have changed during the
COVID-19 pandemic, the factors associated with changes in health service use, if health delayed care remains
unmet once the COVID-19 pandemic subsides, how policy responses (social distancing policies and COVID-
19 vaccination) have impacted care delivery, and how these patterns differ for medically and socially
vulnerable patient populations; 2) Asses PO barriers to adopting telemedicine and assess if PO adoption of
telemedicine lessens adverse health outcomes, particularly among vulnerable patient populations; and 3)
Examine if PO closure or consolidation due to COVID-19 leads to gaps in patient care continuity or access
barriers among vulnerable patient populations. To do so, we will leverage the existing data assets and
expertise of the RAND U19 Center of Excellence that the research team has built over the past 5 years. We
will use 100% Medicare fee-for-service claims data. Findings from this study will help inform an array of
immediate-term and longer-term policies and regulatory changes, including changes to payment policies, use
of technology, financial assistance to providers to ensure their survival, and improving the ability of health
systems to respond to how the COVID-19 pandemic has reshaped the US health care system.
项目摘要/摘要
新冠肺炎疫情对美国的医疗体系和医疗保健造成了前所未有的冲击
为病人送货。正如研究小组记录的那样,新冠肺炎大流行突然而戏剧性地
改变了医疗保健的利用模式,包括远程医疗服务的使用迅速升级,突然
面对面服务的减少,以及大量的延迟服务。目前还不清楚这些护理模式将如何
在大流行的过程中演变(例如,延迟服务将在多大程度上发生,远程医疗
将取代面对面服务,远程医疗服务将保持新的水平),更不用说
新冠肺炎大流行后的几年,以及社会和临床的持续护理模式将如何不同
脆弱的患者群体。医生组织(POS)在快速采用时面临不同的负担
远程医疗和采用远程医疗的PO障碍可能反映在接受以下治疗的患者的结果中
这些位置。面对面护理的减少给许多POS带来了财务压力,导致人们担心
许多邮局可能会倒闭或整合。减少护理的影响,采用远程医疗
作为一种新的护理提供方式,获得POS可能会对脆弱患者产生更大的影响
人口,包括低收入、农村和种族/少数民族人口,以及患有多发性多发性硬化症的患者
慢性疾病。了解患者和提供者对新冠肺炎公共卫生危机的反应
患者,特别是那些在医学和社会上处于弱势的患者所接受的护理,是必要的,告知
旨在帮助卫生提供系统应对新冠肺炎的近期和长期决策--
19.我们建议进行一系列分析,以1)估计医疗服务在
新冠肺炎大流行,与卫生服务使用变化相关的因素,如果卫生保健仍然延误
一旦新冠肺炎大流行平息,政策回应如何(社会疏远政策和CoVID-
接种疫苗)影响了护理服务的提供,以及这些模式在医疗和社会方面的不同之处
脆弱的患者群体;2)评估采用远程医疗的PO障碍,并评估PO是否采用
远程医疗减少不良健康后果,特别是在易受伤害的患者群体中;以及3)
检查由于新冠肺炎导致的PO关闭或整合是否导致患者护理连续性或准入方面的差距
易受伤害患者群体之间的障碍。为此,我们将利用现有数据资产和
研究团队在过去5年中建立的兰德U19卓越中心的专业知识。我们
将使用100%的联邦医疗保险服务收费索赔数据。这项研究的发现将有助于为一系列
近期和较长期的政策和监管变化,包括支付政策的变化,使用
技术,向提供者提供财政援助,以确保他们的生存,并提高保健能力
应对新冠肺炎疫情如何重塑美国医疗体系的系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher Whaley其他文献
Christopher Whaley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher Whaley', 18)}}的其他基金
Health Services Utilization During the COVID-19 Pandemic
COVID-19 大流行期间卫生服务的利用
- 批准号:
10707235 - 财政年份:2022
- 资助金额:
$ 48.15万 - 项目类别:
The Effects of Insurance Benefit Design Innovation on Patient Health
保险福利设计创新对患者健康的影响
- 批准号:
9891936 - 财政年份:2019
- 资助金额:
$ 48.15万 - 项目类别:
The Effects of Insurance Benefit Design Innovation on Patient Health
保险福利设计创新对患者健康的影响
- 批准号:
10993828 - 财政年份:2019
- 资助金额:
$ 48.15万 - 项目类别:
The Effects of Insurance Benefit Design Innovation on Patient Health
保险福利设计创新对患者健康的影响
- 批准号:
10188375 - 财政年份:2019
- 资助金额:
$ 48.15万 - 项目类别:
The Effects of Insurance Benefit Design Innovation on Patient Health
保险福利设计创新对患者健康的影响
- 批准号:
10591613 - 财政年份:2019
- 资助金额:
$ 48.15万 - 项目类别:
The Effects of Insurance Benefit Design Innovation on Patient Health
保险福利设计创新对患者健康的影响
- 批准号:
10356947 - 财政年份:2019
- 资助金额:
$ 48.15万 - 项目类别:
Using Big Data to Estimate the Effects of Complex Cost-Sharing Rules on Colorectal Cancer Screening and Patient Health
使用大数据估计复杂的费用分摊规则对结直肠癌筛查和患者健康的影响
- 批准号:
9373907 - 财政年份:2017
- 资助金额:
$ 48.15万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 48.15万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 48.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 48.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 48.15万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 48.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 48.15万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 48.15万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 48.15万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 48.15万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 48.15万 - 项目类别:
Standard Grant